Is Rituximab-induced Late-onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders?

British Journal of Haematology

Volumn 153, Issue 3, 2011, Pages 411-413

  Hincks, Ian ^a   Woodcock, Barrie E ^a   Thachil, Jecko ^b  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Lymphoma; Neutropenia; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; BONE MARROW EXAMINATION; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPHADENOPATHY; FEMALE; HUMAN; LATE ONSET NEUTROPENIA; LETTER; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NIGHT SWEAT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; NEUTROPENIA; PROGNOSIS; REMISSION INDUCTION;

EID: 79954418051     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08563.x     Document Type: Letter

References (10)

1. Cairoli, R., Grillo, G., Tedeschi, A., D'Avanzo, G., Marenco, P. & Morra, E. (2004) High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation. Haematologica, 89, 361-363.
2. Cattaneo, C., Spedini, P., Casari, S., Re, A., Tucci, A., Borlenghi, E., Ungari, M., Ruggeri, G. & Rossi, G. (2006) Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments. Leukemia & Lymphoma, 47, 1013-1017.
3. Chaiwatanatorn, K., Lee, N., Grigg, A., Filshie, R. & Firkin, F. (2003) Delayed-onset neutropenia associated with rituximab therapy. British Journal of Haematology, 121, 913-918.
4. Dunleavy, K., Hakim, F., Kim, H.K., Janik, J.E., Grant, N., Nakayama, T., White, T., Wright, G., Kwak, L., Gress, R., Tosato, G. & Wilson, W.H. (2005) B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood, 106, 795-802.
5. Hirayama, Y., Kohda, K., Konuma, Y., Hirata, Y., Kuroda, H., Fujimi, Y., Shirao, S., Kobune, M., Takimoto, R., Matsunaga, T. & Kato, J. (2009) Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with rituximab. Internal Medicine, 48, 57-60.
6. Lai, G.G., Lim, S.T., Tao, M., Chan, A., Li, H. & Quek, R. (2009) Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma. American Journal of Hematology, 84, 414-417.
7. Lemieux, B., Tartas, S., Traulle, C., Espinouse, D., Thieblemont, C., Bouafia, F., Alhusein, Q., Antal, D., Salles, G. & Coiffier, B. (2004) Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Bone Marrow Transplantation, 33, 921-923.
8. Nitta, E., Izutsu, K., Sato, T., Ota, Y., Takeuchi, K., Kamijo, A., Takahashi, K., Oshima, K., Kanda, Y., Chiba, S., Motokura, T. & Kurokawa, M. (2007) A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study. Annals of Oncology, 18, 364-369.
9. Voog, E., Morschhauser, F. & Solal-Céligny, P. (2003) Neutropenia in patients treated with rituximab. New England Journal of Medicine, 348, 2691-2694.
10. Wolach, O., Bairey, O. & Lahav, M. (2010) Late-onset neutropenia after rituximab treatment; case series and comprehensive review of the literature. Medicine (Baltimore), 89, 308-318.